Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a lifelong condition that disrupts the gastrointestinal tract and significantly impacts quality of life. While IBD has no…
Calidi Biotherapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Fast Track designation to its experimental therapy, CLD-201 SuperNova, for the treatment of glioblastoma.…
How do you prioritize your responsibility as a caregiver when there is illness in the family? Especially when your husband is facing new rounds of chemotherapy and a fourteen-year-old autistic…
A recent study has revealed encouraging results for mirikizumab, an investigational monoclonal antibody, in addressing one of the most distressing symptoms of Crohn’s disease: bowel urgency. According to Medscape, this…
Each year, nearly half a million Americans are affected by Lyme disease, a tick-borne illness that, if untreated, can lead to serious complications like arthritis, heart issues, and neurological disorders.…
AbbVie, a global biopharmaceutical leader, has reported disappointing results from a phase 2 clinical trial evaluating its interleukin-1 (IL-1) targeting drug, ABBV-668, as a monotherapy for patients with moderate to…
A new Missouri law is shining a spotlight on the vital need for awareness of rare childhood diseases, thanks in large part to the advocacy efforts of a Eureka, Missouri…
Acknowledgement: This poem, originally written by Olivia Thompson, was provided to Patient Worthy by our friends at Elephants & Tea. To see the original, please click here. One welcomes a…
Microbiotica, a UK-based biotechnology company focused on developing microbiome-based therapeutics, has reached a significant milestone by completing patient recruitment for its phase 1b clinical trial in ulcerative colitis (UC). According…
A recent study highlighted by World Pharma News reveals that maintaining a healthy diet can significantly slow the progression of chronic diseases among older adults. Chronic diseases—such as diabetes, heart…
Acknowledgement: This article was originally written by Gillian Sapia, a mother of a child living with galactosemia, for Underground Rare Road. To see the original article, please click here. When…
In our second installment from our series of reports provided by our partner TREND Community, we are going to be focusing on a different condition over the next four weeks. …
Editor's Note: Patient Worthy is honored to share this patient story, which comes to us from our partners at PKD-Free Alliance. Polycystic kidney disease (PKD) has been part of my…
Editor's Note: This story is a continuation of Jenny Decker's global sailing voyage. To see the original article, please click here. Many of our Patient Worthy readers are aware that…
Serina Therapeutics, a clinical-stage biotechnology company, has announced a major development in the treatment of Tardive Dyskinesia (TD) by advancing its innovative POZ-VMAT2i candidate into clinical development. This move, reported…
Here's a more detailed explanation. The newest American Cancer Society study just released suggests that a diagnosis of cancer is no longer a death sentence. According to a recent U.S.…
Acknowledgement: This article was shared with Patient Worthy by our friends at Stork Genetics. To see the original article, please click here. For more information about women affected by X-linked…
Immunotherapy, once considered a niche treatment, has rapidly become a central pillar in the fight against cancer. As detailed in a recent article from Becker’s Hospital Review, this innovative approach…
Researchers have unveiled a groundbreaking laboratory model that could transform the search for new therapies against an aggressive and often lethal blood cancer: acute myeloid leukemia (AML). AML is notorious…
PTC Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of SEPHIENCE™ (sepiapterin), marking the first and only therapy approved for broad treatment of…
In a week of significant developments for the biopharma industry, an FDA advisory committee issued pivotal recommendations on two high-profile blood disorder drugs, while PureTech Health announced a leadership change…
A new Nordic study has revealed a significant link between blood clots caused by paroxysmal nocturnal hemoglobinuria (PNH) and an increased risk of kidney failure. PNH is a rare, life-threatening…
The U.S. Medicaid program has taken a pioneering step to ensure that new gene therapies for sickle cell disease (SCD) are accessible to the millions of Americans who rely on…
Editor's Note: This story was originally authored by Natalie H., a cancer survivor and loving mother of two. They say cancer changes everything. I’ve learned it doesn’t just change you,…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
